Author

Sanne Grievink

Radboud University Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Organism:mouse· 1

Frequent Co-Authors

Geert‐Jan van GemertiD· 2 shared Karina Teelen· 2 shared Matthijs M. JoreiD· 2 shared Rianne Stoter· 2 shared Teun BousemaiD· 2 shared Alfred B. TionoiD· 1 shared Amanda Fabra-GarcíaiD· 1 shared Anna CohuetiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Geert‐Jan van GemertORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Controlled human infection with Plasmodium falciparum-infected mosquito bites elicits antibodies against mosquito salivary protein SG1L3

Carolina M. Andrade, Renate C. van Daalen, Amanda Fabra-García, Sanne Grievink, Geert‐Jan van Gemert, Karina Teelen, Svenja Hester, Rianne Stoter, M. VAN DE VEGTE-BOLMER, CHRIS J. DRAKELEY, Alfred B. Tiono, Robert W. Sauerwein, Teun Bousema, Matthijs M. Jore

The paper identifies human antibodies against a mosquito salivary protein, SG1L3, that binds to Plasmodium falciparum sporozoites but does not block infection.

PLoS Pathogens · Oct 28, 2026Peer-reviewedMicrobiology

Pfs230 Domain 12 is a potent malaria transmission-blocking vaccine candidate

Maartje R. Inklaar, Roos M. de Jong, Dari Frédéric Da, Lisanne Hubregtse, Maartje Meijer, Karina Teelen, Ezra T. Bekkering, Sanne Grievink, Marga van de Vegte‐Bolmer, Geert‐Jan van Gemert, Rianne Stoter, Hikaru Nagaoka, Takafumi Tsuboi, Eizo Takashima, Cornelia G. Spruijt, , Matthijs M. Jore

This study identifies Pfs230 Domain 12 as a potent malaria transmission-blocking vaccine candidate that induces antibodies reducing parasite transmission to mosquitoes.

Science Advances · Nov 7, 2025Peer-reviewedImmunology